GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases
ANKARA, Turkey, Dec 2, 2025 – (ACN Newswire) – GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical…
Indonesia’s KAI Launches Farmer-Trader Train, Expands Facial Recognition Tech Ahead of 2025/2026 Holiday Travel Surge
TransNusa Secures 19 Scheduled Flight Routes Within Three Years of Operations
Criminal IP Reveals Global React2Shell RCE Exposure Across React Server Components
Dental Digital Launches Marketing Services for Dental Practices